{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:58:27Z","timestamp":1787021907978,"version":"build-2736575974"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T00:00:00Z","timestamp":1385424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0081199","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T18:03:49Z","timestamp":1385489029000},"page":"e81199","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Niaspan Attenuates the Adverse Effects of Bone Marrow Stromal Cell Treatment of Stroke in Type One Diabetic Rats"],"prefix":"10.1371","volume":"8","author":[{"given":"Tao","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Zacharek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhuo","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poornima","family":"Venkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/CIRCULATIONAHA.109.192667","article-title":"Heart Disease and Stroke Statistics\u20142010 Update: A Report From the American Heart Association","volume":"121","author":"WG MEMBERS","year":"2010","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1368-5031.2006.00682.x","article-title":"Diabetes mellitus and stroke","volume":"60","author":"I Idris","year":"2006","journal-title":"Int J Clin Pract"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.STR.0000057975.15221.40","article-title":"Association Between Diabetes and Stroke Subtype on Survival and Functional Outcome 3 Months After Stroke: Data From the European BIOMED Stroke Project","volume":"34","author":"S-E Megherbi","year":"2003","journal-title":"Stroke"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/hs1001.096194","article-title":"Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview","volume":"32","author":"SE Capes","year":"2001","journal-title":"Stroke"},{"key":"ref5","first-page":"S15","article-title":"Risk factors and their management for stroke prevention: outlook for 1999 and beyond","volume":"53","author":"RL Sacco","year":"1999","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/STROKEAHA.108.514307","article-title":"Dynamic of Hyperglycemia as a Predictor of Stroke Outcome in the ECASS-II Trial","volume":"39","author":"M Yong","year":"2008","journal-title":"Stroke"},{"key":"ref7","first-page":"588","article-title":"Risk factor analysis in ischaemic stroke: a hospital-based study","volume":"103","author":"AK Basu","year":"2005","journal-title":"J Indian Med Assoc"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.RES.0000063425.51108.8D","article-title":"Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats","volume":"92","author":"J Chen","year":"2003","journal-title":"Circ Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/01.STR.32.4.1005","article-title":"Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats","volume":"32","author":"J Chen","year":"2001","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/096368970000900315","article-title":"Angiogenesis induced by the implantation of self-bone marrow cells: a new material for therapeutic angiogenesis","volume":"9","author":"K Hamano","year":"2000","journal-title":"Cell Transplant"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/sj.jcbfm.9600475","article-title":"Angiopoietin1\/Tie2 and VEGF\/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke","volume":"27","author":"A Zacharek","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1212\/WNL.56.12.1666","article-title":"Treatment of stroke in rat with intracarotid administration of marrow stromal cells","volume":"56","author":"Y Li","year":"2001","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00001756-200103050-00025","article-title":"Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome","volume":"12","author":"D Lu","year":"2001","journal-title":"Neuroreport"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1161\/STROKEAHA.111.627174","article-title":"Adverse Effects of Bone Marrow Stromal Cell Treatment of Stroke in Diabetic Rats","volume":"42","author":"J Chen","year":"2011","journal-title":"Stroke"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2003.07.003","article-title":"Antiatherothrombotic effects of nicotinic acid","volume":"171","author":"RS Rosenson","year":"2003","journal-title":"Atherosclerosis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00041433-200412000-00006","article-title":"Niacin therapy in atherosclerosis","volume":"15","author":"CD Meyers","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.expneurol.2011.09.022","article-title":"Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats","volume":"232","author":"X Ye","year":"2011","journal-title":"Exp Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.21160","article-title":"Niaspan increases angiogenesis and improves functional recovery after stroke","volume":"62","author":"J Chen","year":"2007","journal-title":"Ann Neurol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.nbd.2012.01.001","article-title":"Niaspan increases axonal remodeling after stroke in type 1 diabetes rats","volume":"46","author":"T Yan","year":"2012","journal-title":"Neurobiol Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jama.284.10.1263","article-title":"Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial","volume":"284","author":"MB Elam","year":"2000","journal-title":"Jama"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuroscience.2011.06.004","article-title":"Niaspan reduces high-mobility group box 1\/receptor for advanced glycation endproducts after stroke in type-1 diabetic rats","volume":"190","author":"X Ye","year":"2011","journal-title":"Neuroscience"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1161\/hs1101.098367","article-title":"Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats","volume":"32","author":"J Chen","year":"2001","journal-title":"Stroke"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0014-4886(88)90226-9","article-title":"Seizures and recovery from experimental brain damage","volume":"102","author":"TD Hernandez","year":"1988","journal-title":"Exp Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/jcbfm.1990.47","article-title":"A semiautomated method for measuring brain infarct volume","volume":"10","author":"RA Swanson","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/bjs.5496","article-title":"Increased angiogenic response but deficient arteriolization and abnormal microvessel ultrastructure in critical leg ischaemia","volume":"93","author":"TK Ho","year":"2006","journal-title":"Br J Surg"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.STR.0000038691.03334.71","article-title":"Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials","volume":"33","author":"A Davalos","year":"2002","journal-title":"Stroke"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/nbm.1343","article-title":"Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI","volume":"22","author":"DM Cohen","year":"2009","journal-title":"NMR Biomed"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/STROKEAHA.110.596486","article-title":"White Matter Damage and the Effect of Matrix Metalloproteinases in Type 2 Diabetic Mice After Stroke","volume":"42","author":"J Chen","year":"2011","journal-title":"Stroke"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/bjaceaccp\/mkr018","article-title":"Blood\u2013brain barrier","volume":"11","author":"BK Lawther","year":"2011","journal-title":"Continuing Education in Anaesthesia, Critical Care & Pain"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/01.STR.0000125861.55804.f2","article-title":"Matrix Metalloproteinase-9 and Myeloperoxidase Expression: Quantitative Analysis by Antigen Immunohistochemistry in a Model of Transient Focal Cerebral Ischemia","volume":"35","author":"CM Maier","year":"2004","journal-title":"Stroke"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1749-6632.1999.tb07687.x","article-title":"Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications","volume":"878","author":"S Zucker","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.STR.32.8.1759","article-title":"Matrix Metalloproteinase Expression After Human Cardioembolic Stroke: Temporal Profile and Relation to Neurological Impairment","volume":"32","author":"J Montaner","year":"2001","journal-title":"Stroke"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10072-007-0814-0","article-title":"Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke","volume":"28","author":"V Lucivero","year":"2007","journal-title":"Neurological Sciences"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s000180050210","article-title":"The angiogenins","volume":"54","author":"DJ Strydom","year":"1998","journal-title":"Cell Mol Life Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1745-7270.2008.00442.x","article-title":"Mechanisms of action of angiogenin","volume":"40","author":"X Gao","year":"2008","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"12096","DOI":"10.1073\/pnas.91.25.12096","article-title":"Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities","volume":"91","author":"G Hu","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/eurheartj\/ehm488","article-title":"Plasma angiogenin levels in acute coronary syndromes: implications for prognosis","volume":"28","author":"A Tello-Montoliu","year":"2007","journal-title":"Eur Heart J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1073\/pnas.89.6.2232","article-title":"Angiogenin supports endothelial and fibroblast cell adhesion","volume":"89","author":"F Soncin","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/07853890802001419","article-title":"Elevated angiogenin levels in chronic heart failure","volume":"40","author":"JV Patel","year":"2008","journal-title":"Ann Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000267929","article-title":"Angiogenin levels in the vitreous from patients with proliferative diabetic retinopathy","volume":"28","author":"H Ozaki","year":"1996","journal-title":"Ophthalmic Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/jcp.49.6.508","article-title":"Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease","volume":"49","author":"H Burgmann","year":"1996","journal-title":"J Clin Pathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1203\/00006450-199806000-00013","article-title":"Serum angiogenin levels in children and adolescents with insulin-dependent diabetes mellitus","volume":"43","author":"A Malamitsi-Puchner","year":"1998","journal-title":"Pediatr Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.0014-2972.2001.00958.x","article-title":"Serum angiogenin concentrations in young patients with diabetes mellitus","volume":"32","author":"F Chiarelli","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1474-4422(09)70016-X","article-title":"Matrix metalloproteinases and their multiple roles in neurodegenerative diseases","volume":"8","author":"GA Rosenberg","year":"2009","journal-title":"The Lancet Neurology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.surneu.2005.12.028","article-title":"Inflammation in stroke and focal cerebral ischemia","volume":"66","author":"J Huang","year":"2006","journal-title":"Surg Neurol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/01.WCB.0000037880.62590.28","article-title":"Inflammation and infection in clinical stroke","volume":"22","author":"HC Emsley","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"K Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/ar2939","article-title":"Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis","volume":"12","author":"E Schurgers","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/TP.0b013e31819b3d72","article-title":"Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients","volume":"87","author":"MJ Crop","year":"2009","journal-title":"Transplantation"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2009.12.023","article-title":"Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis","volume":"210","author":"E Bruckert","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1586\/erc.10.116","article-title":"New evidence for nicotinic acid treatment to reduce atherosclerosis","volume":"8","author":"F Montecucco","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI41651","article-title":"Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells","volume":"121","author":"M Lukasova","year":"2011","journal-title":"J Clin Invest"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1368-5031.2004.00233.x","article-title":"Niaspan, the prolonged release preparation of nicotinic acid (niacin), the broad-spectrum lipid drug","volume":"58","author":"LA Carlson","year":"2004","journal-title":"Int J Clin Pract"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/HCO.0b013e3283021c82","article-title":"Nicotinic acid: recent developments","volume":"23","author":"VS Kamanna","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.jacc.2009.06.036","article-title":"Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study","volume":"54","author":"JM Lee","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2008.04.044","article-title":"Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells","volume":"202","author":"SH Ganji","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/jlb.55.3.410","article-title":"Macrophages and angiogenesis","volume":"55","author":"C Sunderk\u00f6tter","year":"1994","journal-title":"Journal of Leukocyte Biology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1038\/sj.bjp.0706400","article-title":"The role of inflammation in CNS injury and disease","volume":"147","author":"SM Lucas","year":"2006","journal-title":"Br J Pharmacol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4196\/kjpp.2011.15.2.115","article-title":"Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice","volume":"15","author":"CH Park","year":"2011","journal-title":"Korean J Physiol Pharmacol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0081199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T00:15:39Z","timestamp":1564877739000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0081199"}},"subtitle":[],"editor":[{"given":"Cesar V.","family":"Borlongan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,26]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0081199","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,26]]}}}